We are live on ! Find out more
CGNT

Cogentix Medical, Inc.
CGNT

Delisted

CGNT was delisted on the 20th of April, 2018.

Back to rankings

47 hedge funds and large institutions have $39.1M invested in Cogentix Medical, Inc. in 2018 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 7

40% more capital invested

Capital invested by funds: $27.9M → $39.1M (+$11.2M)

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

7% more funds holding

Funds holding: 44 → 47 (+3)

Holders
47
Holders Change
+3
Holders Change %
+6.82%
% of All Funds
1.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
13
Reduced
7
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
Beryl Capital Management
California
+$3.31M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.35M
3
Millennium Management
Millennium Management
New York
+$1.07M
4
Renaissance Technologies
Renaissance Technologies
New York
+$928K
5
GLAM
Gardner Lewis Asset Management
Pennsylvania
+$805K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$2.11M
2
PCM
Perkins Capital Management
Minnesota
-$1.37M
3
WPC
White Pine Capital
Minnesota
-$697K
4
BA
Bard Associates
Illinois
-$484K
5
MIH
Meitav Investment House
Israel
-$374K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$87K +$23.4K +7,462 +50%
WPC
27
White Pine Capital
Minnesota
$84K -$697K -222,700 -91%
Citadel Advisors
28
Citadel Advisors
Florida
$82K +$66.4K +21,227 New
First Manhattan
29
First Manhattan
New York
$79K – – –
GC
30
Guggenheim Capital
Illinois
$56K +$278 +89 +0.6%
BBHC
31
Brown Brothers Harriman & Co
New York
$54K – – –
Barclays
32
Barclays
United Kingdom
$49K +$6.88K +2,200 +21%
UBS Group
33
UBS Group
Switzerland
$48K +$39.2K +12,512 New
ARTA
34
A.R.T. Advisors
New York
$44K +$36.5K +11,659 New
SC
35
Searle & Co
Connecticut
$39K – – –
TRCT
36
Tower Research Capital (TRC)
New York
$36K +$26.3K +8,405 +829%
Morgan Stanley
37
Morgan Stanley
New York
$29K +$17.7K +5,646 +282%
Bank of America
38
Bank of America
North Carolina
$26K +$19.3K +6,153 +848%
AF
39
Advisornet Financial
Minnesota
$13K – – –
FWM
40
Focused Wealth Management
New York
$13K – – –
TDC
41
Thompson Davis & Co
Virginia
$12K – – –
US Bancorp
42
US Bancorp
Minnesota
$11K – – –
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$10K +$59 +19 +0.7%
IA
44
IFP Advisors
Florida
$4K – – –
PAM
45
Panagora Asset Management
Massachusetts
$3K -$94.5K -30,205 -97%
WAM
46
Wolverine Asset Management
Illinois
$1K +$1.25K +400 New
BC
47
Broadfin Capital
New York
– -$2.11M -670,812 Closed
BA
48
Bard Associates
Illinois
– -$484K -153,598 Closed
BCM
49
Bridgeway Capital Management
Texas
– -$81K -25,800 Closed
Acadian Asset Management
50
Acadian Asset Management
Massachusetts
– -$78K -24,919 Closed
1
2
3

CGNT Hedge Fund Activity: Q1 2018 in Review

47 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Cogentix Medical, Inc. (CGNT) for Q1 2018, worth a combined $39.1M — up 40% from $27.9M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new CGNT positions and 11 closed out — a net gain of 3 holders — while 13 added to existing stakes and 7 trimmed.

The largest buyer was Beryl Capital Management, opening a new position worth an estimated $3.31M. The largest seller was Broadfin Capital, exiting entirely with an estimated $2.11M sold.

  • 47 institutional investors held Cogentix Medical, Inc. (CGNT) as of Q1 2018, up from 44 in Q4 2017.
  • Funds reported $39.1M of Cogentix Medical, Inc. stock for Q1 2018, up 40% quarter-over-quarter.
  • 14 funds opened new Cogentix Medical, Inc. positions in Q1 2018 and 11 closed out, a net change of +3 holders.
  • The largest Cogentix Medical, Inc. buyer in Q1 2018 was Beryl Capital Management, an estimated $3.31M added.
  • The largest Cogentix Medical, Inc. seller in Q1 2018 was Broadfin Capital, an estimated $2.11M sold.

Based on aggregated 13F filings for Q1 2018.